Bluejay Diagnostics (BJDX) Selling, General & Administrative (2020 - 2026)
Bluejay Diagnostics (BJDX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Bluejay Diagnostics | 1.93 Mn | 1.93 Mn | - | 911,318.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 911,318.00 |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 875,603.00 |
| Sep 30, 2025 | 831,339.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 929,831.00 |
| Sep 30, 2024 | 809,199.00 |
| Jun 30, 2024 | 862,482.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 963,534.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 148,046.00 |
| Dec 31, 2022 | 961,888.00 |
| Sep 30, 2022 | 146,102.00 |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 817,691.00 |
| Sep 30, 2021 | 445,050.00 |